Did Codex DNA, Twist and Ginkgo really warn about product misuse in their SEC filings?
The Codex DNA 2021, Twist 2018 and Ginkgo 2022 SEC filings all contain the misuse warnings the post paraphrases, near word for word; Twist rose 70.1% from its $14 IPO price in year one.
Score
10.0/10
claims that held up
Verdict
Reproduced4
Access needed
L0 Public web onlyRun 28 Oct 2026
We re-ran it and got the claimed kind of result, checked against ground truth.
4
claims scored
all tested
4 of 4
held up in full
4
sites and APIs touched
about 70 seconds
run time
Claim by claim
Codex DNA 2021: bad-actor misuse; insurance may exclude it or fall shortcoreHeld up
S-1/A 2021-06-14 has both sentences.
Twist 2018: can't guarantee measures stop misuse; Select Agent rulescoreHeld up
S-1 2018-10-03 has both; the filing says 'public, animal or plant health'.
Ginkgo 2022: misuse or negligent use hurts reputation and revenuecoreHeld up
S-1/A 2022-04-12, near word for word.
Twist up about 70% in year oneHeld up
$14.00 IPO to $23.82 on 2019-10-31 = +70.1% (Yahoo Finance data).
Open a claim to see what we checked.
- Access it needs
- L0 Public web only
- Run on
- 28 Oct 2026, 08:21 to 08:22 (UTC+8)
- Run by
- Grok Bot
- Check again by
- 27 Nov 2026
What was claimed
'Had Grok dig through SEC filings ... Codex DNA (2021): bad actor could misuse products; insurance may exclude that or be insufficient. Twist Bioscience (2018): can't guarantee measures stop misuse; Select Agent 'severe threat to public health' rules. Ginkgo Bioworks (2022): same misuse/negligent-use language ... Twist +70% in year one.'
@arlogilbert on X. Original post
What we found
Held up. All three filings contain the language the post describes, close to word for word. Codex DNA warns a bad actor could misuse its products and that insurance could exclude such acts or fall short. Twist says it cannot guarantee its biosecurity measures stop misuse and cites Select Agent rules (the filing says public, animal or plant health; the post shortens it). Ginkgo uses the same misuse or negligent use wording and names reputation and revenue as the consequence. Twist rose 70.1% from its IPO price in its first year.
Highlighted words are quoted exactly from a source page or the original post.
How we checked it
SEC EDGAR filings by accession number (Codex DNA 0001628280-21-012119, Twist 0001193125-18-291186, Ginkgo 0001193125-22-103029, Twist 424B4 0001193125-18-314672); excerpts in runs/2026-10-28/sec-biotech-misuse-risk-factors-check/excerpts.json. Answer key written before the run.
What the agent did
- EDGAR full-text search for each company and phrase
- Codex DNA S-1/A 2021-06-14: bad-actor misuse + insurance 'could specifically exclude bad acts ... or coverage limits may be insufficient'
- Twist S-1 2018-10-03: 'cannot guarantee that these preventative measures will eliminate ... the misuse of our products'; Select Agent rules on agents with 'potential to pose a severe threat to public, animal or plant health'
- Ginkgo S-1/A 2022-04-12: 'misuse or negligent use ... our reputation, future revenue, and operating results may suffer'
- Twist: $14.00 IPO (424B4) to $23.82 close on 2019-10-31 = +70.1%
Sites and APIs touched: efts.sec.gov, data.sec.gov, sec.gov, query1.finance.yahoo.com.
Where it went wrong
- The post's other points (AquaBounty, Insys/Juno/bluebird, Codex/Ginkgo -75% to -87%, XBI comparison, the academic study) were not checked.
- Stooq price data was blocked by a JavaScript challenge; the one price check used Yahoo Finance chart data, a single unofficial source.
Try it yourself
Search SEC EDGAR filings for these biotech companies and quote the risk-factor text about misuse of their products: Codex DNA (2021 S-1), Twist Bioscience (2018 S-1), Ginkgo Bioworks (2022 10-K). Confirm the quoted points exist in the filings.
Lowest-access way to try it
L0. Ask the agent to give the accession number and quote the exact risk-factor sentence for each company, not a summary.
Run details
How to cite
TriedAgents, "Did Codex DNA, Twist and Ginkgo really warn about product misuse in their SEC filings?", reproduced, checked 2026-10-28, https://triedagents.com/cases/sec-biotech-misuse-risk-factors-check/
Get one re-run case every weekday
One agent use case we actually re-ran, every weekday. Free.
We only store your email address. Every issue has a one-click unsubscribe link. Privacy